The application of CD73 in minimal residual disease monitoring using flow cytometry in B-cell acute lymphoblastic leukemia

References

• Campana D. Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia. Hematol Oncol Clin North Am 2009; 23: 1083–1098, vii.
   PubMed Web of Science ®Google Scholar
• Bassan R, Spinelli O, Oldani E, et al. Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL). Blood 2009; 113: 4153–4162.
   PubMed Web of Science ®Google Scholar
• Bruggemann M, Raff T, Kneba M. Has MRD monitoring superseded other prognostic factors in adult ALL? Blood 2012; 120: 4470–4481.
   PubMed Web of Science ®Google Scholar
• Meleshko AN, Savva NN, Fedasenka UU, et al. Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols. Leuk Res 2011; 35: 1312–1320.
   PubMed Web of Science ®Google Scholar
• Faderl S, O'Brien S, Pui CH, et al. Adult acute lymphoblastic leukemia: concepts and strategies. Cancer 2010; 116: 1165–1176.
   PubMed Web of Science ®Google Scholar
• Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009; 360: 2730–2741.
   PubMed Web of Science ®Google Scholar
• Bruggemann M, Schrauder A, Raff T, et al. Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia 2010; 24: 521–535.
   PubMed Web of Science ®Google Scholar
• Weng XQ, Shen Y, Sheng Y, et al. Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia. Blood Cancer J 2013; 3: e133.
   Google Scholar
• Fossat C, Roussel M, Arnoux I, et al. Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: a French multicenter study. Cytometry B Clin Cytom 2015; 88: 21–29.
   PubMed Web of Science ®Google Scholar
• Obro NF, Ryder LP, Madsen HO, et al. Identification of residual leukemic cells by flow cytometry in childhood B-cell precursor acute lymphoblastic leukemia: verification of leukemic state by flow-sorting and molecular/cytogenetic methods. Haematologica 2012; 97: 137–141.
   PubMed Web of Science ®Google Scholar
• McKenna RW, Washington LT, Aquino DB, et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood 2001; 98: 2498–2507.
   PubMed Web of Science ®Google Scholar
• Coustan–Smith E, Song G, Clark C, et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood 2011; 117: 6267–6276.
   PubMed Web of Science ®Google Scholar
• Borowitz MJ, Chan JKC. B lymphoblastic leukaemia/lymphoma, not otherwise specified. lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities. In: Swerdlow SH CE, Harris NL, Jaffe ES, etal., editors. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: The International Agency for Research on Cancer (IARC); 2008. p 168–175.
   Google Scholar
• Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783–1786.
   PubMed Web of Science ®Google Scholar
• Babusikova O, Zeleznikova T, Kirschnerova G, et al. Hematogones in acute leukemia during and after therapy. Leuk Lymphoma 2008; 49: 1935–1944.
   PubMed Web of Science ®Google Scholar
• Loken MR, Wells DA. Normal antigen expression in hematopoiesis basis for interpreting leukemia phenotypes. In: Stewart CC, Nicholson JKA, editors. Immunophenotyping. New York: Wiley-Liss; 2000. p 133–160.
   Google Scholar
• Gabert J, Beillard E, van der Velden VH, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -- a Europe Against Cancer program. Leukemia 2003; 17: 2318–2357.
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257–2317.
   PubMed Web of Science ®Google Scholar
• Solly F, Angelot F, Garand R, et al. CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry. Cytometry A 2012; 81: 17–24.
   PubMed Web of Science ®Google Scholar
• DiGiuseppe JA, Fuller SG, Borowitz MJ. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection. Cytometry B Clin Cytom 2009; 76: 150–155.
   PubMed Web of Science ®Google Scholar
• Muzzafar T, Medeiros LJ, Wang SA, et al. Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry. Am J Clin Pathol 2009; 132: 692–698.
   PubMed Web of Science ®Google Scholar
• Diaz D, Prieto A, Barcenilla H, et al. Loss of lineage antigens is a common feature of apoptotic lymphocytes. J Leukoc Biol 2004; 76: 609–615.
   PubMed Web of Science ®Google Scholar
• van der Sluijs-Gelling AJ, van der Velden VH, Roeffen ET, et al. Immunophenotypic modulation in childhood precursor-B-ALL can be mimicked in vitro and is related to the induction of cell death. Leukemia 2005; 19: 1845–1847.
   PubMed Web of Science ®Google Scholar
• Dworzak MN, Gaipa G, Schumich A, et al. Modulation of antigen expression in B-cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: evidence for a drug-induced regulatory phenomenon. Results of the AIEOP-BFM-ALL-FLOW-MRD-Study Group. Cytometry B Clin Cytom 2010; 78: 147–153.
   PubMed Web of Science ®Google Scholar